Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$817K Buy
2,255
+2
+0.1% +$685 0.01% 181
2026
Q1
$793K Buy
2,253
+122
+6% +$43.5K 0.01% 180
2025
Q4
$698K Buy
2,131
+7
+0.3% +$2.22K 0.01% 183
2025
Q3
$599K Sell
2,124
-7
-0.3% -$2.03K 0.01% 190
2025
Q2
$595K Buy
2,131
+4
+0.2% +$1.13K 0.01% 189
2025
Q1
$663K Sell
2,127
-277
-12% -$81.8K 0.01% 170
2024
Q4
$627K Buy
2,404
+278
+13% +$82.5K 0.01% 181
2024
Q3
$685K Sell
2,126
-439
-17% -$144K 0.01% 173
2024
Q2
$801K Buy
2,565
+67
+3% +$19.7K 0.02% 159
2024
Q1
$710K Buy
2,498
+2
+0.1% +$585 0.02% 170
2023
Q4
$719K Sell
2,496
-440
-15% -$120K 0.02% 178
2023
Q3
$789K Sell
2,936
-807
-22% -$201K 0.02% 144
2023
Q2
$831K Buy
3,743
+674
+22% +$156K 0.02% 148
2023
Q1
$742K Sell
3,069
-199
-6% -$48.8K 0.02% 151
2022
Q4
$858K Sell
3,268
-1,549
-32% -$415K 0.02% 146
2022
Q3
$1.21M Buy
4,817
+60
+1% +$14.5K 0.04% 119
2022
Q2
$1.16M Buy
4,757
+74
+2% +$18.1K 0.03% 120
2022
Q1
$1.13M Buy
4,683
+522
+13% +$120K 0.03% 119
2021
Q4
$936K Sell
4,161
-3
-0.1% -$633 0.03% 130
2021
Q3
$885K Buy
4,164
+2,096
+101% +$482K 0.03% 129
2021
Q2
$504K Sell
2,068
-20
-1% -$4.92K 0.02% 166
2021
Q1
$519K Buy
2,088
+970
+87% +$231K 0.02% 152
2020
Q4
$257K Buy
1,118
+205
+22% +$47.3K 0.01% 179
2020
Q3
$232K Buy
+913
New +$226K 0.01% 175
2019
Q1
Sell
-1,609
Closed -$313K 134
2018
Q4
$313K Buy
1,609
+200
+14% +$39K 0.02% 149
2018
Q3
$292K Hold
1,409
0.02% 151
2018
Q2
$260K Sell
1,409
-50
-3% -$8.84K 0.02% 158
2018
Q1
$249K Sell
1,459
-13
-0.9% -$2.39K 0.01% 166
2017
Q4
$256K Buy
1,472
+56
+4% +$9.91K 0.02% 174
2017
Q3
$264K Sell
1,416
-350
-20% -$62K 0.02% 164
2017
Q2
$304K Sell
1,766
-76,582
-98% -$12.5M 0.02% 159
2017
Q1
$12.9M Buy
78,348
+3,084
+4% +$512K 0.84% 37
2016
Q4
$11M Buy
75,264
+3,225
+4% +$485K 0.77% 39
2016
Q3
$12M Sell
72,039
-280
-0.4% -$47.3K 1.8% 13
2016
Q2
$11M Buy
72,319
+2,442
+3% +$380K 1.7% 13
2016
Q1
$10.5M Buy
69,877
+1,936
+3% +$288K 1.71% 12
2015
Q4
$11M Buy
67,941
+1,271
+2% +$200K 1.93% 10
2015
Q3
$9.22M Buy
66,670
+1,463
+2% +$231K 1.66% 15
2015
Q2
$10M Buy
65,207
+1,660
+3% +$266K 1.72% 17
2015
Q1
$10.2M Buy
63,547
+1,885
+3% +$297K 1.25% 19
2014
Q4
$9.82M Sell
61,662
-850
-1% -$132K 1.82% 13
2014
Q3
$8.78M Sell
62,512
-1,762
-3% -$230K 1.8% 16
2014
Q2
$7.61M Buy
64,274
+1,340
+2% +$155K 1.47% 24
2014
Q1
$7.76M Buy
62,934
+105
+0.2% +$12.7K 1.69% 16
2013
Q4
$7.17M Sell
62,829
-70
-0.1% -$7.96K 1.58% 22
2013
Q3
$7.04M Buy
62,899
+1,180
+2% +$128K 1.69% 19
2013
Q2
$6.09M Buy
+61,719
New +$6.4M 1.64% 22

Other funds holding AMGN

Capital Advisors Inc's AMGN Position: Q2 2026 in Review

Capital Advisors Inc increased its Amgen (AMGN) stake by 0.09% in Q2 2026, buying an estimated $685 and bringing the position to 2,255 shares worth $817K. The position accounts for 0.01% of the portfolio, ranked #181.

Capital Advisors Inc first reported a position in AMGN in Q2 2013 and has held it in 47 quarters since. The position peaked at $12.9M in Q1 2017. 1,404 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Capital Advisors Inc held 2,255 shares of Amgen worth $817K as of Q2 2026.
  • Capital Advisors Inc bought 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.01% of Capital Advisors Inc's portfolio in Q2 2026, its #181 holding.
  • Capital Advisors Inc first reported a position in Amgen in Q2 2013 and has held it in 47 quarters since.
  • Capital Advisors Inc's Amgen position peaked at $12.9M in Q1 2017.
  • 1,404 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Capital Advisors Inc's 13F filing for Q2 2026, filed 23 Jul 2026.